ARCHIVES

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

This article is from The Cancer Letter archive.

Vol. 24 No. 47 | December 11, 1998

Download PDF Visit The Full Archive

Related Articles

Talbot, Schein Ask Weickar for 41.3 Billion for NCI

May 6, 1983

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

Group Chairman Balk At Board’s Recommendations

February 15, 1980

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Diet & Nutrition Workshops Planned

March 14, 1975

Harvest Yet To Come From Radiotherapy Advances, Kaplan Tells NCAB

October 17, 1975